Dabigatran (Pradaxa®)

TA 327. Guidance to be developed

  • Traffic Light
    Amber (G)
  • BNF
    2.8.2
  • Licensed Indicators
    Treatment and prevention of VTE
  • Reference
    APC 2015
  • Criteria
  • Provisional
    No

Do you want to add this to your CPD record?

Did you find this page helpful?